# Nuclide record f-18-naf (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/f-18-naf/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "f-18-naf" ;
  schema:name "Sodium fluoride F-18"@en ;
  schema:alternateName "18F-NaF"@en, "Na18F"@en, "Fluoride F-18"@en ;
  schema:description "A radioactive form of fluoride that collects in areas of bone rebuilding. A PET scan after the injection shows those hot spots, which can be cancer that has spread to bone or something harmless like a healed fracture."@en ;
  schema:url <https://nuclide.cc/drugs/f-18-naf/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d867a881-108e-41fa-91ab-dc4df00cbb55>, <https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022494Orig1s000Approv.pdf> ;
  nuclide:status "approved" ;
  nuclide:tag "bone imaging", "PET", "generic" ;
  nuclide:modality "PET tracer" ;
  nuclide:approval "US 1972: Diagnostic PET imaging of bone to define areas of altered osteogenic activity (NDA 17-042)", "US 2011: Diagnostic PET imaging of bone to define areas of altered osteogenic activity (NDA 22-494, current labelling)" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/tc-99m/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:companies <https://nuclide.cc/companies/ge-healthcare/> .